Medical Device

Medtronic Recognized for its Commitment to Promoting Environmental Stewardship

Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the world's largest medical technology, services, and solutions company — has been named on the 2021 list of Canada's Greenest Employers.

Medtronic Canada ULC Logo (CNW Group/Medtronic Canada ULC)

This Mediacorp award recognizes leading companies across the nation that create and embody a culture of environmental awareness within their organizations. From developing environmental initiatives to reducing the company's environmental footprint and advocating for active employee engagement, the focus on environmental sustainability is embedded in the culture and identity of Medtronic Canada.

One tenet of the company's Mission speaks to maintaining good citizenship as a company, and listening to employees is ingrained in its culture. "Our senior leadership team endorses green practices," said Neil Fraser , president of Medtronic Canada, "not only because it's the right thing to do, but because it's also what our employees want."

Under the guidance of Surinder Sehdev , senior manager of Environmental Health, Safety and Sustainability in Canada , Medtronic has undertaken a number of environmental initiatives, both as a company and as a collective of employees.

As a founding member of the Canadian Coalition for Green Health Care, Medtronic supports the integration of environmentally responsible practices in the field of healthcare. For example, Medtronic takes complete ownership of its medical devices until explantation from the patients, when the company ensures proper disposal or recycling of parts such as batteries or precious metals. Approximately 10,000 Medtronic medical devices are recycled each year in Canada .

Medtronic also partners with community organizations, such as the Ontario Electronic Stewardships program to boost recycling of electronics in company offices and surrounding communities.

In 2009, Medtronic's new Brampton head office opened with a LEED Silver energy and environmental designation - the first Medtronic office globally to be certified. The building also has a reflective roof to reduce cooling loads, high efficiency LED lighting, non toxic interiors and a living wall of moss at the entrance.

Other corporate initiatives include preferential parking for employees driving electric and hybrid cars, tree planting through the Quality Begins with Me program, provision of additional points for RFP respondents with environmental sustainability programs as part of the procurement process.

"We're doing our best to be stewards for the environment," said Mr. Sehdev. "The expense is high, but the environmental value is greater. The return on our investment in sustainability supports our Mission."

In 2021, Medtronic has also been recognized by Forbes as one of Canada's Best Employers and ranked among Canada's Top 50 Employers and Best Workplaces for Women . In 2020, Canada's Top 100 Employers and the GTA's top employers by Mediacorp. It was also ranked one of Canada's Best Workplaces in Healthcare , one of the Best Workplaces for Mental Wellness in Canada , and one of the Best Workplaces in Ontario by the Great Place to Work Institute of Canada .

Medtronic is the largest medical device employer in Canada , with over 1,100 employees. In 2020 alone, Medtronic innovation and technology benefitted 75 million people globally — that's two people every second.

About Medtronic Canada ULC
Proudly serving Canadian healthcare for over 50 years, Medtronic Canada ULC ( ) is a subsidiary of Medtronic plc, the world's largest medical technology, services, and solutions companies — alleviating pain, restoring health, and extending life for millions of people around the world. Serving physicians, hospitals, and patients across the country, Medtronic Canada ULC is headquartered in Brampton, Ontario , with regional offices in Montreal and Vancouver , and a Medtronic Resource Centre in Surrey, BC . The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the U.S. Securities and Exchange Commission. Actual results may differ materially from anticipated results.

SOURCE Medtronic Canada ULC

Cision View original content to download multimedia:

News Provided by Canada Newswire via QuoteMedia

Medtronic to announce financial results for its fourth quarter and full fiscal year 2022

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2022 on Thursday, May 26, 2022 . A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at . The news release will include summary financial information for the company's fourth quarter and full fiscal year 2022, which ended on Friday, April 29, 2022 .

Medtronic will host a video webcast at 7:00 a.m. CDT on Thursday , May 26, 2022, to discuss financial results for its fourth quarter and full fiscal year 2022. The webcast can be accessed at .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

  • Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life
  • Findings demonstrate TriClip™ transcatheter edge-to-edge (TEER) repair is effective at reducing tricuspid regurgitation across a broad range of anatomies
  • One-year outcomes for Navitor™ transcatheter aortic valve implantation (TAVI) system show the safety and effectiveness of this therapy and durable performance of the sealing cuff in minimizing paravalvular leak for patients with severe aortic stenosis

Abbott (NYSE: ABT) today announced two late-breaking data presentations highlighting both TriClip™, a first-of-its kind minimally invasive tricuspid heart valve repair device, and Navitor™, the company's latest-generation transcatheter aortic valve implantation (TAVI) system. The company also showcased new data for MitraClip™ and Amplatzer™ Amulet™, two key components of the company's industry-leading structural heart portfolio.

All data were presented at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions, held in Paris from May 17-20, 2022 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Thermo Fisher Scientific Declares Quarterly Dividend

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on May 18, 2022, its Board of Directors authorized a quarterly cash dividend of $0.30 per common share, payable on July 15, 2022, to shareholders of record as of June 15, 2022.

About Thermo Fisher Scientific

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Premier Health Reports FY2022 Second Quarter Results

Premier Health Reports FY2022 Second Quarter Results

Premier Health of America Inc. (TSXV: PHA ) (the " Corporation "), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and Management Discussion and Analysis for its second quarter ended March 31, 2022.


News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022

XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU ® Research Posters Will Be Presented

Bausch Health Companies Inc. (NYSETSX: BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and disorders, today announced seven posters on behalf of XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® (polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution), will be shared at Digestive Disease Week® (DDW) 2022 which is being held virtually and in-person in San Diego, Calif. from May 21-24, 2022 . The posters will be accessible on DDW's ePoster's website beginning Saturday, May 21, 2022 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

EuroPCR: Medtronic renal denervation system shows better blood pressure control with significantly more time in target range

Medtronic adds to SPYRAL HTN Global Clinical Program with late breaking clinical data for SPYRAL HTN-ON MED and GSR-DEFINE

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced data showing the benefits of the Symplicity Blood Pressure Procedure with the Symplicity Spyral™ Renal Denervation (RDN) system on achieving target blood pressure level ranges. As part of the SPYRAL HTN Global Clinical Program, three-year data from SPYRAL HTN-ON MED and GSR-DEFINE were presented at EuroPCR 2022 as late-breaking clinical trials on May 17, 2022.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News